Related Experiment Video
Updated: Jun 8, 2026
07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
How to integrate current knowledge in selecting patients for first line in NSCLC?
Summary
New strategies are needed for advanced non-small-cell lung cancer (NSCLC) as standard chemotherapy offers limited survival. Targeted therapies, including EGFR and ALK inhibitors, show promise for specific NSCLC patient subsets.
Area of Science:
- Oncology
- Medical Research
Background:
- Non-small-cell lung cancer (NSCLC) is the leading cause of cancer mortality, with most patients diagnosed at advanced stages.
- Current platinum-based chemotherapy for NSCLC has a limited median survival of approximately one year, indicating a need for improved first-line treatments.
Purpose of the Study:
- To review current challenges and emerging strategies in first-line treatment for advanced non-small-cell lung cancer.
- To highlight the potential of targeted therapies based on specific molecular alterations.
Main Methods:
- Review of current treatment standards and recent clinical trial data for advanced NSCLC.
- Discussion of emerging targeted therapies, including bevacizumab, EGFR inhibitors, and ALK inhibitors.
Main Results:
- Bevacizumab combined with chemotherapy improves outcomes in selected advanced non-squamous NSCLC patients.
- EGFR mutation testing is crucial, with EGFR tyrosine kinase inhibitors offering a first-line option for patients with sensitizing mutations.
- ALK inhibitors show promising results in NSCLC patients with ALK rearrangements, identifying ALK as a new therapeutic target.
Conclusions:
- First-line treatment for advanced NSCLC requires personalized approaches, considering chemotherapy, targeted agents, and maintenance strategies.
- Ongoing research focuses on targeted therapies and precise patient selection for improved outcomes in NSCLC.
Related Concept Videos
01:29Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...